Work

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

Year: 2011

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-011-0687-1

Authors: David A. Reardon, Andrew D. Norden, Annick Desjardins, James J. Vredenburgh, James E. Herndon, April Coan, John H. Sampson, Sridharan Gururangan, Katherine B. Peters, Roger E. McLendon, Julie A. Norfleet, Eric S. Lipp, Jan Drappatz, Patrick Y. Wen, Henry S. Friedman

Institutions: Duke Medical Center, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Duke University

Language: English

Topic: Meningioma and schwannoma management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G2071192811, G3199277650, G3424063223, SRC on Primary Tumors of the CNS

OpenAlex ID: W2028032241

FWCI: 5.395

Cites: 41

Cited by: 94

Related to: 10